November 1, 2018
Chronic disease management startup Livongo announced a handful of new offerings and partnerships this week, all organized around the theme of “Applied Health Signals,” a framework for thinking about the technologies and capabilities Livongo offers.
“Health Signals is really an enabling technology,” Amar Kendale, Livongo’s chief product officer, told MobiHealthNews. “Something that is part of all...
November 1, 2018
AdhereTech, a seven-year-old digital health startup focused on smart pill bottles and medication adherence, has raised a round of growth equity funding, its first since 2014. The company didn’t disclose the amount of the investment, which came from New York-based Argentum.
The company has deals with six top 30 pharma companies and all the major specialty pharmas, CEO Josh Stein told...
October 16, 2018
Hero — a medication adherence system consisting of a countertop device, refill service, and connected app — has launched today to consumers on the back of $12 million in Series A funding.
The three-pillar platform is built for patients as well as their caregivers, and looks to reduce the stress and difficulty that each side faces when daily drug regimens begin to escalate, Kal Vepuri, founder and...
October 10, 2018
Children’s Health, a Texas-based pediatric health system, is teaming up with Proteus to pilot a new program aimed at tackling adherence issues in pediatric heart transplant patients by inserting ingestible sensors into prescribed pills, which can track when the medication was taken.
The system is made up of a wearable patch worn by the patient and the sensor-infused pill. When the pill is broken...
August 29, 2018
Sempre Health, a San Francisco-based company that uses monetary incentives and pricing to encourage healthy behaviors, announced today that it has obtained $8 million in Series A financing. Rethink Impact was the lead investor, and was joined by Social Capital and other unnamed backers.
“We are incredibly excited to invest in Sempre Health as it uses its core technology to tackle the nearly $300...
August 27, 2018
A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.
The investigation was conducted by a group of Australian researchers, and included a sample of 163 adults participants with an average age of roughly 58 years. Presented this week at the European Society of...
June 22, 2018
Medication management and adherence app maker Medisafe has announced a partnership with Boehringer Ingelheim following a successful pilot.
Medisafe will offer a wraparound app experience that incorporates Pradaxa-specific educational information into a special version of its app, which patients will be directed to when they're prescribed the drug.
"Pradaxa is not different than any other...
June 6, 2018
Yesterday’s announcement that Apple would open the API for Health Records in iOS 12 will likely spawn a whole host of integrations with digital health companies in the coming months. But one company has the distinction of being named in the announcement, and of having its Health Records integration already complete: Medisafe.
The Boston-based company has been making medication management and...
April 27, 2018
Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.
Because TB is, airborne, highly infectious, and increasingly resistant to antibiotics, treatment and prevention of the disease often...
April 19, 2018
Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.
Launched in 2016, the web- and mobile-based RespiPoints program offers patients a variety of adherence-...